| BCSFX | BCSVX | BCSFX / BCSVX | |
| Total Expense Ratio | 1.06 | 1.31 | 81% |
| Annual Report Gross Expense Ratio | 1.06 | 1.31 | 81% |
| Fund Existence | 11 years | 11 years | - |
| Gain YTD | -8.527 | -8.699 | 98% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 500000 | 5000 | 10,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 689M | 689M | 100% |
| Annual Yield % from dividends | 0.87 | 0.41 | 213% |
| Returns for 1 year | -19.07 | -19.28 | 99% |
| Returns for 3 years | 0.68 | -0.09 | -722% |
| Returns for 5 years | -20.43 | -21.44 | 95% |
| Returns for 10 years | 92.51 | 87.65 | 106% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| PLXGX | 21.79 | 0.27 | +1.25% |
| Virtus KAR Capital Growth I | |||
| OMSCX | 26.46 | 0.21 | +0.80% |
| Invesco Main Street All Cap C | |||
| FIKVX | 14.73 | N/A | N/A |
| Fidelity Advisor Asset Manager 20% Z | |||
| MCGRX | 18.12 | -0.15 | -0.82% |
| BlackRock Natural Resources Inv C | |||
| PHPSX | 36.83 | -1.51 | -3.94% |
| ProFunds Pharmaceuticals UltraSector Svc | |||